Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1948 (LINC01948) is a human long intergenic non-coding RNA (lincRNA), classified as a transcript longer than 200 nucleotides that does not overlap protein-coding genes[1][3][5][7]. Like other lincRNAs, LINC01948 is thought to participate in gene regulation primarily through remodeling chromatin, modulating transcription, stabilizing other RNAs, and fine-tuning the expression of neighboring genes, often with tissue specificity[3][5]. While many lincRNAs have undetermined biological significance, some—including LINC01948—have been implicated as potential risk markers or functional contributors in cancer, though direct mechanistic or therapeutic targeting information for LINC01948 specifically is not yet available[2][6]. It is not an enzyme, receptor, transporter, or transcription factor, and whether it is a bona fide therapeutic target has not been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1948 (LINC01948).